Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Apr;63(4):483. doi: 10.1038/bjc.1991.115

Has the MOPP era ended?

G P Canellos
PMCID: PMC1972342  PMID: 2021529

Full text

PDF

Page 483

483

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonadonna G., Valagussa P., Santoro A. Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. Ann Intern Med. 1986 Jun;104(6):739–746. doi: 10.7326/0003-4819-104-6-739. [DOI] [PubMed] [Google Scholar]
  2. Devita V. T., Jr, Serpick A. A., Carbone P. P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970 Dec;73(6):881–895. doi: 10.7326/0003-4819-73-6-881. [DOI] [PubMed] [Google Scholar]
  3. Druker B. J., Rosenthal D. S., Canellos G. P. Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease. Cancer. 1989 Mar 15;63(6):1060–1064. doi: 10.1002/1097-0142(19890315)63:6<1060::aid-cncr2820630603>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  4. Klimo P., Connors J. M. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program. Semin Hematol. 1988 Apr;25(2 Suppl 2):34–40. [PubMed] [Google Scholar]
  5. Longo D. L., Young R. C., Wesley M., Hubbard S. M., Duffey P. L., Jaffe E. S., DeVita V. T., Jr Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol. 1986 Sep;4(9):1295–1306. doi: 10.1200/JCO.1986.4.9.1295. [DOI] [PubMed] [Google Scholar]
  6. McElwain T. J., Toy J., Smith E., Peckham M. J., Austin D. E. A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer. 1977 Aug;36(2):276–280. doi: 10.1038/bjc.1977.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McKendrick J. J., Mead G. M., Sweetenham J., Jones D. H., Williams C. J., Ryall R., Whitehouse J. M. ChlVPP chemotherapy in advanced Hodgkin's disease. Eur J Cancer Clin Oncol. 1989 Mar;25(3):557–561. doi: 10.1016/0277-5379(89)90270-8. [DOI] [PubMed] [Google Scholar]
  8. Santoro A., Bonadonna G., Valagussa P., Zucali R., Viviani S., Villani F., Pagnoni A. M., Bonfante V., Musumeci R., Crippa F. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol. 1987 Jan;5(1):27–37. doi: 10.1200/JCO.1987.5.1.27. [DOI] [PubMed] [Google Scholar]
  9. Selby P., Patel P., Milan S., Meldrum M., Mansi J., Mbidde E., Brada M., Perren T., Forgeson G., Gore M. ChlVPP combination chemotherapy for Hodgkin's disease: long-term results. Br J Cancer. 1990 Aug;62(2):279–285. doi: 10.1038/bjc.1990.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Valagussa P., Santoro A., Fossati Bellani F., Franchi F., Banfi A., Bonadonna G. Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. Blood. 1982 Mar;59(3):488–494. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES